“…While access to animal tissues is typically plentiful, the availability of human cardiac samples is limited. When available, human tissues have typically been limited to fixed or frozen samples or very small amounts of fresh and viable tissues which were obtained from surgical discards (Boukens et al, 2015; Jost et al, 2005, 2013; Brandenburger et al, 2015; Näbauer, Beuckelmann, Überfuhr, & Steinbeck, 1996; Näbauer & Kääb, 1998; Wettwer et al, 1993; Wettwer, Amos, Posival, & Ravens, 1994). However, in the past, tissue recovery procedures, as well as tissue quality and quantity have been extremely variable, resulting in an unreliable source for robust and reproducible drug safety data.…”